Should Labs Add Lp(a) Testing to Their Menus?
Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.
Category: Cardiovascular
Cardiovascular
Latest
Cardiovascular
Latest
Researchers Identify Potential Prenatal Biomarkers of Congenital Heart Diseases
The biomarker could enable prenatal detection of single ventricle heart disease through a maternal blood test for earlier diagnosis.
Cardiovascular
Latest
Increased Testing for Heart Disease Indicator Needed
A new review finds that 20% of the global population carries a genetic risk for cardiovascular diseases due to high levels of lipoprotein(a).
Roche’s Lipoprotein Blood Test Gets Breakthrough Device Designation
Roche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Read More
A Genetic Test for Early Cardiovascular Risk Detection
Researchers developed a genetic testing procedure that can identify patients at high risk for cardiovascular diseases.
Read More
Advanced Cardiovascular POC Testing System Gets FDA Clearance
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Read More
FDA Clears Cardiac Troponin I Test for Myocardial Infarction Diagnosis
The new high-sensitivity troponin assay is designed for use on the the PATHFAST Biomarker Analyzer from Polymedco.
Read More
Heart Failure Monitoring Tech Doubles Sensitivity for Predicting Events Versus Standard of Care
Bodyport says its biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events.
Read More
Blood Biomarkers Help Predict Cardiovascular Disease Risk in Rheumatoid Arthritis Patients
The measurement of six blood biomarkers improved the ability of researchers to predict a future increase in arterial inflammation.Â
Read More
How a Standard Blood Test Helps Predict Heart Attacks
Combining the results of a standard blood test and an online tool can help identify those who are at risk of having a heart attack.
Read More
Biomarkers to Predict Cardiovascular Risks in Type 2 Diabetes Patients Identified
Researchers extracted data on 321 biomarkers and found 13 were significantly associated with cardiovascular risk in type 2 diabetes patients.
Read More
Two Common Biomarkers Predict Heart Risk in Asymptomatic Childhood Cancer Survivors
The biomarkers may help more quickly predict cardiomyopathy in high-risk, asymptomatic childhood cancer survivors.Â
Read More
Two-Step Screening Strategy Could Reduce Diabetic Heart Failure
A two-step screening protocol can effectively identify which patients with Type 2 diabetes need medication to prevent heart failure.
Read More
New Test Aids Emergency Diagnosis of Heart Conditions
Patients with a heart muscle injury caused by other heart conditions benefitted the most from the new troponin measurement method.
Read More
Bio-Rad Expands Instrument Compatibility for Cardiac Advance Control
Bio-Rad Laboratories expanded the compatibility of its newest cardiac control, Cardiac Advance, to now include Beckman-Coulter instruments. Â
Read More
Earlier Detection of Pediatric Cardiometabolic Risk Factors through Next-Gen Biomarkers
Next-gen cardiometabolic biomarkers will aid earlier detection of risk factors for obesity, diabetes, and heart disease in children.
Read More
Mindray Expands Cardiac Biomarker Portfolio with New Assays
Mindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.
Read More
New Blood Test Measures Levels of Critical Omega-3 Fatty Acids
Researchers discovered a way to track levels of omega-3 fatty acids in the bloodstream to gain information critical to cardiovascular health.
Read More